Discordant p53 Gene Mutations in Primary Head and Neck Cancers and Corresponding Second Primary Cancers of the Upper Aerodigestive Tract

Cancer Research

Volumn 53, Issue 7, 1993, Pages 1676-1683

  Casson, Alan ^a,d   Ro, Jae Y ^a   Kim, Jhingook ^a   Roth, Jack A ^a,c  

^a Department of Thoracic Surgery ^*  (Canada)

^b Department of Otolaryngology   (Canada)

^c UNIVERSITY OF TEXAS   (United States)

^d VICTORIA HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CARCINOGENESIS; CLINICAL ARTICLE; DIGESTIVE SYSTEM CANCER; DNA DETERMINATION; DNA SEQUENCE; ETIOLOGY; EXON; FEMALE; GENE MUTATION; HEAD AND NECK CANCER; HUMAN; HUMAN TISSUE; MALE; NUCLEIC ACID BASE SUBSTITUTION; PRIORITY JOURNAL; RESPIRATORY TRACT CANCER; SECOND CANCER; TUMOR SUPPRESSOR GENE;

ADULT; AGED; AMINO ACID SEQUENCE; CARCINOMA, SQUAMOUS CELL; DNA MUTATIONAL ANALYSIS; ESOPHAGEAL NEOPLASMS; EXONS; FEMALE; GENES, P53; HEAD AND NECK NEOPLASMS; HUMAN; LUNG NEOPLASMS; MALE; MIDDLE AGE; MOLECULAR SEQUENCE DATA; MUTATION; NEOPLASMS, MULTIPLE PRIMARY; POLYMERASE CHAIN REACTION; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0027415517     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Licciardello, J. T. W., Spitz, M. R., and Hong. W. K. Multiple primary cancer in patients with cancer of the head and neck: second cancer of the head and neck, esophagus, and lung. Int. J. Radiat. Oncol. Biol. Phys., 17: 467-476, 1989.
2. Cooper, J. S., Pajak, T. F., Rubin, P., Tupchong, L., Brady, L. W., Leibel, S. A., Laramore, G. E., Marcial, V. A., Davis. L. W., and Cox, J. D. Second malignancies in patients who have head and neck cancer: incidence, effect on survival and implications based on the RTOG experience. Int. J. Radiat. Oncol. Biol. Phys., 17: 449-456, 1989.
3. Franco, E. L., Kowalski, L. P., and Kanda, J. L. Risk factors for second cancers of the upper respiratory and digestive systems: a case-control study. J. Clin. Epidemiol., 44: 615-625, 1991.
4. Slaughter, D. P., Southwick, H. W., and Smejkal, W. “Field cancerization” in oral stratified squamous epithelium. Cancer (Phila.), 6: 963-968, 1953.
5. Levine, A. J., Momand, J., and Finlay, C. A. The p53 tumour suppressor gene. Nature (Lond.), 351: 453-456, 1991.
6. Takashi, T., Carbone. D., Takahashi, T., Nau, M. M. Hida, T., Linnoila, I., Ueda, R., and Minna, J. D. Wild-type but not mutant p53 suppresses the growth of human lung cancer cells bearing multiple genetic lesions. Cancer Res., 52: 2340-2343, 1992.
7. Gerwin, B. I., Spillare, E., Forrester, K., Lehman, T. A., Kispert, J., Welsh, J. A., Pfeifer, A. M. A., Lechner, J. F., Baker, S. J., Vogelstein, B., and Harris, C. C. Mutant p53 can induce tumorigenic conversion of human bronchial epithelial cells and reduce their responsiveness to a negative growth factor, transforming growth factor Bt. Proc. Natl. Acad. Sci. USA, 89: 2759-2763, 1992.
8. Lavigueur, A., Maltby, V., Mock, D., Rossant, J., Pawson, T., and Bemsteink, A. High incidence of lung, bone, and lymphoid tumors in transgenic mice overexpressing mutant alleles of the p53 oncogene. Mol. Cell. Biol., 9: 3982-3991. 1989.
9. Nigro, J. M., Baker, S. J., Preisinger, A. C., Jessup, J. M., Hostetter, R., Cleary, K., Bigner, S. H., Davidson, N., Baylin, S., Devilee, P., Glover, T., Collins, F. S., Weston, A., Modali, R., Harris, C. C., and Vogelstein, B. Mutations in the p53 gene occur in diverse human tumor types. Nature (Lond.), 342: 705-708, 1989.
10. Chiba, I., Takahashi, T., Nau, M. M., D'Amico, D., Curiel, D. T., Mitsudomi, T., Buchhagen, D. L., Carbone, D., Piantadosi, S., Koga, H., Reissman, P. T., Slamon, D. J., Holmes, E. C., and Minna, J. D. Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Oncogene, 5: 1603-1610, 1990.
11. Iggo, R., Gatter, K., Bartek, J., Lane, D., and Harris, A. L. Increased expression of mutant forms of p53 oncogene in primary lung cancer. Lancet, 335: 675-679, 1990.
12. Damico, D., Carbone, D., Mitsudomi, T., Nau, M., Fedorko, J., Russell, E., Johnson, B., Buchhagen, D., Bodner, S., Phelps, R., Gazdar, A., and Minna, J. D. High frequency of somatically acquired p53 mutations in small-cell lung cancer cell lines and tumors. Oncogene, 7: 339-346, 1992.
13. Dolcetti, R., Maestro, R., Feriotto, G., Pelucchi, S., Rizzo, S., and Boiocchi, M. p53 genetic abnormalities in human squamous cell carcinomas of the larynx. Oncogene, 6: 44-45, 1990.
14. Hollstein, M. C., Metcalf, R. A., Welsh, J. A., Montesano, R., and Harris, C. C. Frequent mutation of the p53 gene in human esophageal cancer. Proc. Natl. Acad. Sci. USA, 87: 9958-9959 1, 1990.
15. Meltzer, S. J., Yin, J., Huang, Y., McDaniel, T. K., Newkirk, C., Iseri, O., Vogelstein, B., and Resau, J. H. Reduction to homozygosity involving p53 in esophageal cancers demonstrated by the polymerase chain reaction. Proc. Natl. Acad. Sci. USA, 88: 4976-4980, 1991.
16. Casson, A. G., Mukhopadhyay, T., Cleary, K. R., Ro, J. Y., Levin, B., and Roth, J. A. p53 gene mutations in Barrett's epithelium and esophageal cancer. Cancer Res., 51: 4495-4499, 1991.
17. Hollstein, M. C., Peri. L., Mandard, A. M., Welsh, J. A., Montesano, R., Metcalf, R. A., Bak, M., and Harris, C. C. Genetic analysis of human esophageal tumors from two high incidence geographic areas: frequent p53 base substitutions and absence of ras mutations. Cancer Res., 51: 4102-4106, 1991.
18. Bennett, W. P., Hollstein, M. C., He, A., Zhu, S. M., Resau, J. H., Trump, B. F., Metcalf, R. A., Welsh, J. A., Midgley, C., Lane, D. P., and Harris, C. C. Archival analysis of p53 genetic and protein alterations in Chinese esophageal cancer. Oncogene. 6: 1779-1784, 1991.
19. Blount, P. L. Ramel, S., Raskind. W. H., Haggitt, R. C., Sanchez. C. A. Dean, P. J. Rabinovitch, P. S., and Reid, B. J. 17 allelic deletions and p53 protein overexpression in Barrett's adenocarcinoma. Cancer Res., 51: 5482-5486, 1991.
20. Tamura, G., Maesawa, C., Suzuki, Y., Satodate, R., Ishida, K., and Saito, K. p53-gene mutations in esophageal cancer detected by polymerase chain reaction single-strand conformation polymorphism analysis. Jpn. J. mutations in esophageal cancer detected by polymerase chain reaction single-strand conformation polymorphism analysis. Jpn. J. Cancer Res., 83: 559-562, 1992.
21. Somers. K. D., Merrick. M. A., Lopez, M. E., Incognito, L. S., Schechter, G. L., and Casey, G. Frequent p53 mutations in head and neck cancer. Cancer Res., 52: 5997-6000, 1992.
22. Bennett, W. P. Hollstein, M. C., Metcalf, R. A., Welsh, J. A., He, A. Zhu, S. M., Kusters, I., Resau, J. H., Trump, B. F., Lane, D. P., and Harris, C. C. p53 mutation and protein accumulation during multistage human esophageal carcinogenesis. Cancer Res., 52: 6092-6097, 1992.
23. Sozzi, G., Miozzo, M., Donghi, R., Pilotti, S., Cariani, C. T., Pastorino, U., Dellaporta, G., and Pierotti, M. A. Deletions of 17p and p53 mutations in preneoplastic lesions of the lung. Cancer Res., 52: 6079-6082, 1992.
24. Dolcetti, R., Doglioni, C. Maestro, R., Gasparotto, D., Barzan, L., Pastore, A., Romanelli, M., and Boiocchi, M. p53 over-expression is an early event in the development of human squamous-cell carcinoma of the larynx-genetic and prognostic implications. Int. J. Cancer, 52: 178-182, 1992.
25. Sundaresan, V., Ganly, P., Hasleton, P., Rudd, R., Sinha, G., Bleehen, N. M., and Rabbits, P. p53 and chromosome-3 abnormalities, characteristic of malignant lung tumours, are detectable in preinvasive lesions of the bronchus. Oncogene. 7: 1989-1997, 1992.
26. Vahakangas, K. H., Samet. J. M., Metcalf. R. A. Welsh, J. A., Bennett, W. P., Lane, D. P., and Harris, C. C. Mutations of p53 and ras genes in radon-associated lung cancer from uranium miners. Lancet, 339: 576-580, 1992.
27. Ramel, S. Reid, B. J., Sanchez, C. A. Blount, P. L., Levine, D. S., Neshat, K., Haggitt, R. C., Dean, P. J., Thor, K., and Rabinovitch, P. S. Evaluation of p53 protein expression in Barrett's esophagus by two-parameter flow cytometry. Gastroenterology, 102: 1220-1228, 1992.
28. Sundaresan, V., Ganly, P. S., Hasleton, P., Rudd, R., Sinha, G., Bleehen, N. M., and Rabbitts, P. H. Genetic changes in pre-invasive lesions of the respiratory tract. Lung Cancer, 7 (Suppl.); 17, 1991.
29. Sameshima, Y., Matsuno, Y., Hirohashi, S., Shimosato, Y., Mizoguchi, H., Sugimura, T., Terada, M., and Yokota, J. Alterations of the p53 gene are common and critical events for the maintenance of malignant phenotypes in small-cell lung carcinoma. Oncogene, 7: 451-457, 1992.
30. Sidransky, D., Mikkelsen, T., Schwechheimer, K., Rosenblum, M. L., Cavanee, W., and Vogelstein, B. Clonal expansion of p53 mutant cells is associated with brain tumour progression. Nature (Lond.). 355: 846-847, 1992.
31. Schlegel. U., Rosenfeld, M., and Fumeaux, H. p53 mutations in metastatic tumors. Proc. Am. Assoc. Cancer Res., 32: 315, 1991.
32. Warren, S., and Gates, O. Multiple primary malignant tumor: a survey of the literature and a statistical study. Am. J. Cancer, 16: 1358-1414, 1932.
33. Batsakis, J. G. Synchronous and metachronous carcinomas in patients with head and neck cancer. Int. J. Radiat. Oncol. Biol. Phys., 10: 2163-2164, 1984.
34. Gluckman, J., and Crissman, J. D. Survival with multiple neoplasm of the upper aerodigestive tract. Laryngoscope, 93: 71-74, 1983.
35. Hollstein, M., Sidransky, D., Vogelstein, B., and Harris, C. C. p53 mutations in human cancers. Science (Washington DC), 253: 49-53, 1991.
36. Jones, P. A., Buckley, J. D., Henderson. B. E., Ross, R. K., and Pike, M. C. From gene to carcinogen: a rapidly evolving field in molecular epidemiology. Cancer Res., 51: 3617-3620, 1991.
37. Orita, M., Iwahana, H., Kanazawa, H., Hayashi, K., and Sekiya, T. Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc. Natl. Acad. Sci. USA, 86: 2766-2770, 1989.
38. Orita, M., Suzuki, Y., Sekiya, T., and Hayashi, K. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics, 5: 874-879, 1989.
39. Saiki, R. K., Gelfand, D. H., Stoffel, S., Scharf, S. J., Higuchi, R., Horn, G. T., Mullis, K. B., and Erlich, H. A. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science (Washington DC), 239: 487-491, 1988.
40. Levine, M. S., Caroline, D., Thompson, J. J., Kressel. H. Y., Laufer, I., and Herlinger, H. Adenocarcinoma of the esophagus: relationship to Barrett mucosa. Radiology, 150: 305-309, 1984.
41. Matte, G., Gouveia, J., Hercend, T., Gros, F., Dorual, T., Han, Z., and Misset, J. L. Correlation between cancerous bronchial metaplasia and cigarette consumption, and preliminary results of retinoid treatment. Cancer Detect Prev., 5: 461-466, 1982.
42. Stich, H. F., Rosin, M. P., Hornby, A. P., Mathew, B., Sankaranarayanan, R., and Nair, M. K. Remission of oral leukoplakias and micronuclei in tobacco/betel quid chewers treated with 0-carotene and β-carotene plus vitamin A. Int. J. Cancer, 42: 195-199, 1988.
43. Schottenfeld, D. The role of alcohol and tobacco in multiple primary cancer of the upper digestive system, larynx, and lung: a prospective study. Prev. Med., 3: 277-293, 1974.
44. Schantz, S. P., and Hsu, T. C. Head and neck cancer patients express increased clastogen-induced chromosome fragility. Head Neck Surg., 11: 337-343, 1989.
45. Goyette, M. C., Cho, K., Fasching, C. L., Levy, D. B., Kinzler, K. W., Paraskeva. C., Vogelstein, B., and Stanbridge, E. J. Progression of colorectal cancer is associated with multiple tumor suppressor gene defects but inhibition of tumorigenicity is accomplished by correction of any single defect via chromosome transfer. Mol. Cell. Biol., 12: 1387-1395, 1992.
46. Lippman, S. M., and Hong, W. K. Second malignant tumors in head and neck squamous carcinoma: the overshadowing threat for patients with early stage of disease. Int. J. Radiat. Oncol. Biol. Phys., 17: 691-694, 1989.
47. Bressac, B. Galvin, K. M. Liang, T. J. Isselbacher. K. J. and Wands, J. R. Abnormal structure and expression of p53 gene in human heptatocellular carcinoma. Proc. Natl. Acad. Sci. USA, 87: 1973-1977. 1990.
48. Rodrigues, N. R. Rowan, A., Smith, M. E. F., Kerr. I. B., Bodmer, W. F., Gannon, J. V., and Lane, D. P. p53 mutations in colorectal cancer. Proc. Natl. Acad. Sci. USA, 87: 7555-7559, 1990.
49. Sakai, E., and Tsuchida, N. Most human squamous cell carcinomas in the oral cavity contain mutated p53 tumor-suppressor genes. Oncogene, 7: 927-933, 1992.
50. Lane, D. P., and Benchimol, S. p53: oncogene or anti-oncogene? Genes & Dev., 4: 1-8, 1990.
51. Mukhopadhyay, T., Cavender, A. C., Branch, C. D., and Roth, J. A. Expression and regulation of wild type p53 gene (wtp53) in human non-small cell lung cancer (NSCLC) cell lines carrying normal or mutated p53 gene. J. Cell. Biochem., Suppl. 15F: 22, 1991.
52. Takahashi, T., Nau, M. M., Chiba, I., Birrer, M. J., Rosenberg, R. K., Vinocour, M., Levitt, M., Pass, H., Gazdar, A. F., and Minna, J. D. p53: a frequent target for genetic abnormalities in lung cancer. Science (Washington DC), 246: 491-494, 1989.
53. Field, J. K., Spandidos, D. A., Malliri, A., Gosney, J. R., and Yiagnisis, M. Elevated p53 expression correlates with a history of heavy smoking in squamous cell carcinoma of the head and neck. Br. J. Cancer, 64: 573-577, 1991.
54. Hayashi, K. Mutations induced during the polymerase chain reaction. Technique, 2: 216-217, 1990.
55. Ogden, G. R., Kiddie, R. A., Lunny, D. P., and Lane, D. P. Assessment of p53 protein expression in normal, benign, and malignant oral mucosa. J. Pathol. 166: 389-394, 1992.
56. Slebos, R. J. C., Kibbelaar, R. E., Dalesio, O., Kooistra, A., Stam, J., Meijer, C. J. M., Wagenaar, S. S., Vanderschueren, R. G. J. R. A., Van Zandwijk, N., Mooi, W. J., Bos, J. L., and Rodenhuis, S. K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung. N. Engl. J. Med., 323: 561-565, 1990.
57. Fearon, E. R., and Jones, P. A. Progressing toward a molecular description of colorectal cancer development. FASEB J., 6: 2783-2790, 1992.
58. Lu, X., Park, S. H., Thompson, T. C., and Lane, D. P. ras-induced hyperplasia occurs with mutation of p53, but activated ras and myc together can induce carcinoma without p53 mutation. Cell, 70: 153-161, 1992.
59. Momand, J., Zambetti, G. P., Olson, D. C., George, D., and Levine, A. J. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell, 69: 1237-1245, 1992.
60. Roth, J. A. New approaches to treating early lung cancer. Cancer Res., 52 (Suppl.): S2652-S2657, 1992.
61. Sidransky, D., Frost, P., Von Eschenbach, A., Oyasu, R., Preisinger, A. C., and Vogelstein, B. Clonal origin of bladder cancer. N. Engl. J. Med., 326: 737-740, 1992.
62. Che, P-L., Chen, Y., Shan, B., Bookstein, R., and Lee, W-H. Stability of retinoblastoma gene expression determines the tumorigenicity of reconstituted retinoblastoma cells. Cell Growth & Differ., 3: 119-125, 1992.